Copan launches UriVerse, a fully automated system designed to streamline urine specimen aliquoting, reducing errors and improving efficiency for labs worldwide.
 |
| Copan's UriVerse system automates urine specimen aliquoting, improving laboratory efficiency and reducing manual labor. Now available for labs across the United States. Image: Copan |
Murrieta, California — August 13, 2025:
Copan Diagnostics, a leader in laboratory automation, has officially launched UriVerse, a cutting-edge automated system designed to optimize urine specimen aliquoting and streamline laboratory workflows. The new system was unveiled at the Association for Diagnostics & Laboratory Medicine (ADLM) Clinical Lab Expo in Chicago, Illinois, on August 12, 2025, marking a significant milestone in the evolution of laboratory automation.
UriVerse automates critical pre-analytical steps such as de-capping, barcode labeling, aliquoting, and re-capping. These essential tasks, which were traditionally done manually, can now be performed by UriVerse with enhanced speed, accuracy, and consistency. This advancement is particularly crucial as laboratories continue to handle increasing volumes of urine specimens, especially in chemistry and toxicology testing.
Urine specimens are a major component of a laboratory's daily workload, yet tasks like aliquoting are often still done by hand, leading to variability and increased labor costs. UriVerse addresses these challenges by automating repetitive, error-prone tasks, allowing labs to reduce manual labor, minimize human error, and improve the overall efficiency of specimen processing.
The system features advanced capabilities such as continuous, random-access loading, automated cup recognition, and integrated aliquoting, labeling, and capping. By eliminating manual pipetting and specimen sorting, UriVerse enables labs to manage rising specimen volumes without compromising accuracy or turnaround times.
"Copan continues to drive the future of laboratory automation with technologies like UriVerse," said Fabrizio Mazzocchi, CEO of Copan Diagnostics. "With this innovative solution, we offer labs an efficient, reliable tool to meet the growing demands of urine testing, particularly in the fields of chemistry and toxicology, while ensuring better specimen traceability and reducing the risks associated with manual processes."
UriVerse is designed to integrate seamlessly into existing laboratory workflows, addressing key pain points such as increasing workload, personnel shortages, and rising expectations for faster testing results. By automating critical tasks, UriVerse ensures that labs can handle growing specimen volumes with greater consistency and speed.
Following its successful debut at the ADLM Expo, UriVerse is now available in the United States directly through Copan Diagnostics. This new automation system joins Copan’s extensive portfolio of laboratory solutions, including WASP and WASPLab, further cementing the company’s leadership in specimen collection, transport, and pre-analytical automation.
As laboratories across the world face growing demands for faster and more accurate testing, Copan’s UriVerse promises to be a transformative tool, helping labs manage specimen volumes efficiently while minimizing human error and operational costs.